https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=Kura_Oncology%2C_Inc.Kura Oncology, Inc. - Revizia istoricului2026-04-05T12:27:38ZIstoricul versiunilor pentru această pagină din wikiMediaWiki 1.39.2https://wiki.tradeville.ro/index.php?title=Kura_Oncology,_Inc.&diff=427789&oldid=prevAdmin: Pagină nouă: Pagina dedicata companiei Kura Oncology, Inc. listata cu simbolul US.KURA ==Descriere companie== Kura Oncology, Inc. (www.kuraoncology.com) is a clinical-stage biopharmaceutical company. The Company’s segment is engaged in discovery and development of medicines for the treatment of cancer. Its pipeline consists of small molecule product candidates that target cancer signaling pathways. It is developing its lead product candidate, tipifarnib, which is a farnesyl transferase...2024-09-18T18:08:28Z<p>Pagină nouă: Pagina dedicata companiei Kura Oncology, Inc. listata cu simbolul US.KURA ==Descriere companie== Kura Oncology, Inc. (www.kuraoncology.com) is a clinical-stage biopharmaceutical company. The Company’s segment is engaged in discovery and development of medicines for the treatment of cancer. Its pipeline consists of small molecule product candidates that target cancer signaling pathways. It is developing its lead product candidate, tipifarnib, which is a farnesyl transferase...</p>
<p><b>Pagină nouă</b></p><div>Pagina dedicata companiei Kura Oncology, Inc. listata cu simbolul US.KURA<br />
<br />
==Descriere companie==<br />
Kura Oncology, Inc. (www.kuraoncology.com) is a clinical-stage biopharmaceutical company. The Company’s segment is engaged in discovery and development of medicines for the treatment of cancer. Its pipeline consists of small molecule product candidates that target cancer signaling pathways. It is developing its lead product candidate, tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and hematologic indications. It is developing KO-539, a small molecule inhibitor of the Lysine K-specific Methyltransferase 2A (KMT2A) interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).<br />
<br />
==Grafic actiuni companie==<br />
<iframe key="tradeville" path="graficSimbol/US.KURA" /><br />
<br />
==Ultimele stiri despre Kura Oncology, Inc. (US.KURA)==<br />
<dynamicpagelist><br />
category=US.KURA<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
<br />
[[Categorie:US.KURA]][[Categorie:Stiri despre companii]]</div>Admin